Radiopharm Theranostics Limited (RADX) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Radiopharm Theranostics L...

NASDAQ: RADX · Real-Time Price · USD
6.20
0.14 (2.31%)
At close: Oct 03, 2025, 3:55 PM
6.29
1.45%
After-hours: Oct 03, 2025, 05:41 PM EDT

Radiopharm Theranostics Cash Flow Statement

Financials in AUD. Fiscal year is July - June.
Fiscal Year Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023
Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023
Net Income
n/a n/a n/a n/a n/a
Depreciation & Amortization
n/a n/a n/a n/a n/a
Stock-Based Compensation
n/a n/a n/a n/a n/a
Other Working Capital
n/a n/a n/a n/a n/a
Other Non-Cash Items
-33.46M -26.62M -13.15M -6.11M -1.91M
Deferred Income Tax
n/a n/a n/a n/a n/a
Change in Working Capital
n/a n/a n/a n/a n/a
Operating Cash Flow
-33.46M -26.62M -13.15M -6.11M -1.91M
Capital Expenditures
n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a
Other Investing Acitivies
3M 3M n/a n/a n/a
Investing Cash Flow
3M 3M n/a n/a n/a
Debt Repayment
2.2M 2.2M 2.2M 2.2M n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a
Other Financial Acitivies
-11.07M -9.06M -1.97M -300K -134K
Financial Cash Flow
64.58M 68.7M 29.95M 7.16M 1.98M
Net Cash Flow
34.54M 44.6M 16.74M 1.1M 60K
Free Cash Flow
-33.46M -26.62M -13.15M -6.11M -1.91M